Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes

Authors:

Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by inattention, hyperactivity-impulsivity, or both.1 The prevalence of ADHD has been estimated to be approximately 5%.2 Although symptoms start in childhood, they often persist into adulthood, with an estimated ADHD prevalence of 2.5% among adults.3 ADHD often co-occurs with other psychiatric disorders, such as communication disorders, intellectual and learning disabilities, autism spectrum disorders, mood disorders, anxiety disorders, and substance use disorders.1 Heterogeneity in symptom profiles and psychiatric comorbidities are challenges in the treatment of ADHD in children, adolescents, and adults.

This publication has 30 references indexed in Scilit: